WATCH: During the 2024 ASCO Annual Meeting, Andrea Roman, PharmD BCOP, discussed a study showing how remote pharmacists can improve cancer medication safety and regimens, as well as providing support for community physicians. #ASCO24 #RemotePharmacists #Oncology #ClinicalReviews https://lnkd.in/gaGZr5Zc
The US Oncology Network
Hospitals and Health Care
The Woodlands, TX 37,878 followers
Driving success at every level of your oncology practice.
About us
Every day, The US Oncology Network helps over 2,500+ providers deliver value-based, integrated care for patients—close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network provides doctors with access to coordinated resources, best business practices, and the experience, infrastructure and support of McKesson. This collaboration allows the doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Together, The Network and its affiliated physicians are committed to the success of independent practices, everywhere. For more information, visit www.usoncology.com.
- Website
-
http://www.usoncology.com
External link for The US Oncology Network
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- The Woodlands, TX
- Type
- Public Company
- Founded
- 1999
- Specialties
- Healthcare Oncology Pharmacy
Locations
-
Primary
10101 Woodloch Forest Dr
The Woodlands, TX 77380, US
-
-
-
Employees at The US Oncology Network
Updates
-
With modern advancements in research and treatment, cancer outcomes are improving more and more. Today, cancer is frequently a chronic illness, and one with which patients can often live a high quality of life for many years. Clinical trials, cancer research, and awareness initiatives have all contributed to the many advances that enabled this shift, and we are hopeful that many more advances will be made in the years to come. #ChronicDiseaseDay #CancerResearch #ClinicalTrials
-
-
Last month, Texas Oncology and DeepScribe announced a collaboration to reduce administrative burden for providers using DeepScribe's AI solutions. To make the scribing process as seamless as possible, DeepScribe has integrated its AI documentation into Ontada's EHR, iKnowMed. "Working with DeepScribe aligns perfectly with our mission to advance cancer care for all Texans," said Steve Paulson, M.D., president and CEO of Texas Oncology. "This innovative technology not only allows our clinicians to reduce time spent on documentation by significant hours each day, but also strengthens our ability to deliver better care.” Together, The US Oncology Network and Ontada create innovative solutions for practices and providers, attracting collaboration with some of the most impactful organizations in oncology and helping liberate physicians from their keyboards so they can spend more time with patients. Learn more: https://lnkd.in/grJsUJBc #AI #CommunityOncology #Innovation #CancerCare
-
One of the ways we support practices in The Network is by collaborating with organizations that enable better health outcomes for all. Our social care platform, which helps practices navigate social services on behalf of patients, is powered by one such organization—Findhelp. Learn more about our collaboration with Findhelp: https://lnkd.in/gXDfy34e #SocialServices #CommunityOncology
-
-
We are thrilled to announce that New Jersey Cancer Care (NJCC) has joined forces with Regional Cancer Care Associates (RCCA)! This partnership brings together NJCC's dedication to community-based oncology care and RCCA's extensive resources and expertise. Dr. James Orsini Sr., founder of NJCC, stated, “RCCA is the perfect fit for our practice, sharing our commitment to cutting-edge therapies and patient-centered care.” This collaboration ensures that NJCC’s patients will continue receiving high-quality, compassionate care, now enhanced by RCCA’s robust data analytics and clinical support. With offices in Belleville, Montclair, and Roselle, NJCC has been a leader in cancer care since 1998. Now, as part of RCCA’s network of over 90 specialists across 22 locations, NJCC will benefit from expanded clinical trials and innovative treatment options. We welcome the physicians and staff of NJCC to The Network! Together, we are stronger and more equipped to provide premier oncology care to communities across the nation.
-
-
WATCH: Dr. David Andorsky of Rocky Mountain Cancer Centers discusses an ongoing study of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). This study aims to demonstrate the feasibility of outpatient administration of Epcoritamab and other biospecifics that currently require hospitalization during a patient's first full dose. #Hematology #Epcoritamab #Biospecific #ASCO24
-
-
The Network is proud to facilitate site visits with members of Congress and state legislatures at practices in The Network to highlight the importance of policies supporting accessible, affordable, and high-quality care in the community setting. We would like to express our gratitude to Rep. Diana DeGette and Rocky Mountain Cancer Centers for their contribution in showcasing how patients access clinical trials in the community setting in the Denver metroplex area.
Thank you to Rocky Mountain Cancer Centers for joining The US Oncology Network’s dinner event with Rep. Diana DeGette in downtown Colorado this past week. It was truly a pleasure to share more about the great work being done in the Denver metroplex area connecting patients with cutting edge research and access to clinical trials in the community setting. It was also great to share the importance of private practice viability and pressures faced from consolidation. We look forward to working with Rep. DeGette as she continues to be a leader in health care on the House Energy & Commerce Committee.
-
-
July is Sarcoma & Bone Cancer Awareness Month. This rare cancer type accounts for approximately 1% of adult cancers and 15-20% of childhood cancers. Unfortunately, sarcoma is often resistant to existing treatment methods, and there is a need for new therapeutic options. Clinical trials and research play a vital role in improving treatment options and overall survival for these cancers. #ClinicalTrials #SarcomaAwarenessMonth #BoneCancerAwareness #CancerResearch
-
-
Practices in The Network are committed to providing patients with the highest quality care possible. One of the ways they do this is by investing in cutting-edge technology, which enables better care and improved efficiency. For example, Shenandoah Oncology has made significant investments in its lab and now has a brand new Ortho XT3400, allowing the practice to better serve its patients. #CommunityOncology #Technology #PatientCare
Exciting news alert! 🎉🔬 Shenandoah Oncology Lab is stepping up our game to better serve you! 💪✨ We are thrilled to announce that we are making significant investments in our lab to enhance our capabilities and deliver even faster results. ⚡️🔍 Introducing our brand-new Ortho XT3400, this instrument has cutting-edge technology that will revolutionize our testing process. 🌟 This state-of-the-art laboratory analyzer will allow us to bring more testing in-house, meaning quicker turnaround times and improved efficiency. 💯🚀 At Shenandoah Oncology, our top priority is providing you with the highest quality service and care. By investing in this advanced technology, we aim to streamline our operations and deliver your results sooner, ensuring a smoother and more efficient experience for all. 🙌💙 Stay tuned for more updates as we continue to innovate and improve our services. We are so grateful for your trust and support, and we can't wait to bring you the best possible lab experience! 🌈🔬 #ShenandoahOncologyLab #Innovation #CuttingEdge #BetterTogether #FasterResults #QualityCare
-
-
Thank you to Misty Chicchirichi, Sr. Quality Programs Manager at Shenandoah Oncology, and Evan Osborne, MBA, MPH, BSRT(T) (ARRT), PMP, Value-Based Care Program Manager at The Network, for representing The Network at the 2024 CMS Health Equity Conference! Misty had the honor of presenting as part of a distinguished panel, shedding light on the groundbreaking work being done by Shenandoah Oncology to promote health equity. Her presentation was nothing short of inspiring, as she discussed various initiatives including HRSN screening, Findhelp utilization, lay navigation, and Health Equity Planning. As we continue to navigate the complex challenges of health equity, it is crucial to celebrate the progress being made. Together, we can create a future where health equity is a reality for every individual. #HealthEquity #CMSHealthEquityConference #SocialDeterminantsOfHealth
-